This company has been marked as potentially delisted and may not be actively trading. NYSE:GLS Gelesis (GLS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Gelesis Stock (NYSE:GLS) 30 days 90 days 365 days Advanced Chart Get Gelesis alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.11▼$0.3352-Week Range N/AVolume185,100 shsAverage Volume386,034 shsMarket Capitalization$11.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.Read More… Receive GLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gelesis and its competitors with MarketBeat's FREE daily newsletter. Email Address GLS Stock News HeadlinesGelesis Holdings Inc GLSHQDecember 9, 2023 | morningstar.comNYSE to suspend trading immediately in Gelesis HoldingsApril 11, 2023 | msn.comFrom Social Security to Social Prosperity?In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.April 28, 2025 | Paradigm Press (Ad)NYSE to Suspend Trading Immediately in Gelesis Holdings, Inc. (GLS) and Commence Delisting ProceedingsApril 10, 2023 | finance.yahoo.comLooking Into Gelesis Holdings's Return On Capital EmployedMarch 29, 2023 | msn.comGelesis Reports Fourth Quarter and Full Year 2022 ResultsMarch 28, 2023 | finance.yahoo.comGLS Gelesis Holdings, Inc.January 27, 2023 | seekingalpha.comGelesis to Participate in the 25th Annual ICR ConferenceJanuary 5, 2023 | finance.yahoo.comSee More Headlines GLS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Gelesis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Gelesis investors own include VIQ Solutions (VQS), Faraday Future Intelligent Electric (FFIE), Eos Energy Enterprises (EOSE), Danimer Scientific (DNMR), Crown ElectroKinetics (CRKN), Boxed (BOXD) and BitNile Metaverse (BNMV). Company Calendar Today4/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:GLS CIK1805087 Webwww.gelesis.com PhoneN/AFaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-56,030,000.00 Net Margins-221.38% Pretax Margin-214.62% Return on EquityN/A Return on Assets-14.98% Debt Debt-to-Equity RatioN/A Current Ratio0.30 Quick Ratio0.21 Sales & Book Value Annual Sales$25.77 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.34) per share Price / BookN/AMiscellaneous Outstanding Shares73,333,000Free Float64,606,000Market Cap$11.63 million OptionableNot Optionable Beta0.88 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NYSE:GLS) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gelesis Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gelesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
